Wells Fargo raises Disc Medicine price target to $124
Bullish based on the target increase and implied upside, though conviction is limited without the prior target or rationale.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Bullish based on the target increase and implied upside, though conviction is limited without the prior target or rationale.
What happened, with direct paths to the underlying reporting
Wells Fargo raised its price target for IRON to $124 versus the posted price of $78.93, implying about 57% upside. This is an analyst estimate; the record does not provide the prior target or supporting rationale.
Target: $124
Posted price: $78.93
Analyst firm: Wells Fargo
Analyst: Derek Archila
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.